What Really Happened During the Massive SARS-CoV-2 Omicron Wave in China?
JAMA Intern Med
.
2023 Jul 1;183(7):633-634.
doi: 10.1001/jamainternmed.2023.1547.
Authors
John P A Ioannidis
1
2
3
,
Francesco Zonta
4
,
Michael Levitt
5
Affiliations
1
Meta-Research Innovation Center at Stanford, Stanford University, Stanford, California.
2
Department of Medicine, Stanford University, Stanford, California.
3
Department of Epidemiology and Population Health, Stanford University, Stanford, California.
4
Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University, Shanghai, China.
5
Department of Structural Biology, Stanford University, Stanford, California.
PMID:
37184847
PMCID:
PMC10404134
DOI:
10.1001/jamainternmed.2023.1547
No abstract available
Plain language summary
This Viewpoint discusses reports from China after its zero COVID-19 policy ended in December 2022.
MeSH terms
COVID-19* / epidemiology
China / epidemiology
Humans
SARS-CoV-2*
Grants and funding
R35 GM122543/GM/NIGMS NIH HHS/United States